Clinical trial
The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU
NCT03786887 is registered in ClinicalTrials.gov with Hua-Qing Shu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU
- Lead sponsor
- Hua-Qing Shu
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 24, 2018
- Completion date
- October 31, 2019
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.